Johannesburg, 13 th August 2009 Outstanding Business Action to Stop TB: How Companies Contribute to the Global Fight 2009 TB Case Studies Shuma Panse Global.

Johannesburg, 13th August 2009

Outstanding Business Action to Stop TB: How Companies Contribute

to the Global Fight2009 TB Case Studies

Shuma PanseGlobal Business Coalition on HIV/AIDS, TB and Malaria (New York office)

GBC Case Studies

2

GBC Case Studies:

• Inspire readers with unique programs and innovative leveraging of core competencies

• Motivate by documenting concrete and measurable program outcomes

• Provide action-oriented guidance and critical success factors

• Grouped by industry or intervention type for target audiences

GBC identifies, collects, synthesizes and disseminates best practices in private sector engagement on HIV, TB and malaria

Case Study Collections

3

Current Publications

GBC Awards for Business Excellence (Annual Winner Profiles)

Travel & Tourism: Guidebook and Case Studies

In Good Company: How Business Fights the Feminization of HIV/AIDS

Outstanding Business Action to Stop TB: How Companies Contribute to the Global Fight

Coming Soon: Malaria Case Studies Publication (in partnership with the World Economic Forum)

4

Online Case Studies

Companies’ Response to Engagement in activities around tuberculosis

TB information and education

Strategies to prevent transmission in workplace &/or community

Integration of TB &HIV activities

Treatment regimen in line with NTP and Int'l Standards (DOT)

Early identification of TB suspects and prompt diagnosis

Only 40% of companies surveyed offer TB information and education in the workplace (n=83)

Why TB Case Studies?

6

Outstanding Business Action to Stop TB: Who, What & Why

Every industry has a role to play in tackling

TB!

Four Action AreasWorkplace

Community

Core Competence

Advocacy

Eli Lilly X XChevron X X XAstraZeneca X XOgilvy Healthworld

X X

BD X XAnglogold Ashanti

X

Bayer Healthcare

X

Barrick Gold X X

Though the type of intervention, scale and outcome of each program may vary, all of them share the following elements:

• Corporate commitment to stopping TB• Initial focus on risk assessment• Integrated approach to disease management• Partnerships with TB stakeholders

Diverse Programs With Shared Elements

Each case study includes:

9

BUSINESS OVERVIEW

PROGRAM DESCRIPTION

CRITICAL SUCCESS FACTORS

Advocacy Profile:

• Health Communications & Marketing Competencies

• Message Mapping for HIV & TB

R&D Profile:

• Assess the use of moxifloxacin in the treatment of TB

• Partnership with the TB Alliance for Drug Development

GBC TB Tools & Resources

2009 TB Case Studies

Issue Briefs

M&E CD-ROM

Together, we can Stop TB

Photo Credit: James Nachtwey (www.XDRTB.org)